Endocrine oncology

Clinically Significant Central Lymph Node Metastasis is Not Common in Patients with Clinically N0 Papillary Thyroid Carcinoma on Both Ultrasonography and Computed Tomography (CT)

ThyroidPublished Retrospective cohort study

Authors' conclusion

Most LNs confirmed after CLND in cN0 PTC patients assessed by USG and CT were either metastasis-free or classified as low-risk metastatic LNs. Furthermore, the majority of metastatic LNs were small in size, typically measuring <1 cm.

Study context

Population
Patients with clinically node-negative papillary thyroid carcinoma (PTC) (no suspicious metastatic lymph node (LNs) on preoperative ultrasonography (USG) and neck CT) who underwent thyroidectomy with prophylactic central lymph node dissection (p-CLND), January 2000 to September 2022
Participants
3,002 patients
Outcome
Central LN metastasis status

Main finding

As reported in the abstract

Central LN metastases
1194 (39.7%)
No central LN metastases
1808 (60.3%)
Intermediate-risk metastases
507 (16.9%)
Low-risk LN metastases (<2 mm, ≤5 metastatic LNs)
610 (20.3%)
Low-risk LN metastases or no central LN metastases
2428 (80.5%)
High-risk metastases
77 (2.5%)

Observational data: associations, not effects.

Further findings

Disease recurrence · median follow-up 4.52 (IQR: 1.6-7.5) years — between No LN metastases and Low-risk LN metastases · across the three groups

P = 0.012

Size of central LN metastases among 584 with intermediate-/high-risk metastases

Central LN metastases <1 cm
577 (98.8%)
Central LN metastases ≥1 cm
7 (1.2%)

Factors independently associated with intermediate-/high-risk central LN metastases

Age <55 years, OR
2.29
Male sex, OR
2.33
Tumor size >1 cm on USG, OR
1.94
Extrathyroidal extension on CT, OR
1.53
  • p < 0.001 for all factors

Original publication

Clinically Significant Central Lymph Node Metastasis is Not Common in Patients with Clinically N0 Papillary Thyroid Carcinoma on Both Ultrasonography and CT. Thyroid. Published 31 March 2025. doi:10.1089/thy.2024.0484

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.